Treatment Plan: Mr. Prabhat Chandra Chaturvedi, 66M, Type 2 DM on Metformin 500mg OD Night

Summary of Key Lab Findings

1. DIABETES MANAGEMENT (Primary Focus)

Current Status

• HbA1c is 7.6% - above the ADA 2025 target of <7% for most adults (or <7.5% may be acceptable for a 66-year-old with comorbidities)
• Fasting glucose persistently elevated (~126-138 mg/dL over 3 readings)
• Currently on underdosed Metformin (500mg OD) - target is 1500-2000mg/day

Treatment Modifications

• Increase Metformin to 500mg BD or 1000mg OD at night (with food to minimize GI side effects)
• GFR is 88 - safe to use (metformin is safe down to eGFR >30; caution below 45)
• Target: 1500-2000mg/day gradually

2. THYROID - IMPORTANT NOTE

• Previous TSH was 6.771 µIU/mL (elevated - subclinical hypothyroidism)
• Current TSH = 1.664 µIU/mL (now NORMAL)

• He was treated with levothyroxine and is now adequately controlled, OR
• The TSH normalized spontaneously

• Confirm if patient is already on levothyroxine - if yes, continue and monitor TSH every 6 months
• If not on any thyroid treatment, repeat TSH in 3 months to confirm stability
• Note: Hypothyroidism worsens insulin resistance and glycemic control - adequately treated thyroid disease will also help improve HbA1c

3. MACROCYTOSIS + THROMBOCYTOPENIA - Must Address

• Metformin is a well-documented cause of B12 malabsorption, which produces macrocytosis
• Tintinalli's Emergency Medicine confirms: "Medications that affect folate absorption or metabolism and produce macrocytosis include... metformin"

• Check Serum Vitamin B12 level and Serum Folate urgently
• Check peripheral blood smear to look for hypersegmented neutrophils (megaloblastic)
• If B12 low: Start Methylcobalamin 500mcg TDS orally or Mecobalamin injections 1000mcg IM weekly x 4 doses then monthly
• The thrombocytopenia and lymphocytosis alongside macrocytosis also warrants ruling out:
  • Viral etiology (EBV, CMV - lymphocytosis)
  • Hematological disorders (peripheral smear, LDH, reticulocyte count)
  • If platelet count drops further below 100, consider hematology referral

4. URIC ACID - Borderline

• Current: 6.79 mg/dL (normal upper limit 7.20) - improving from previous 7.51
• Not yet requiring pharmacotherapy, but:
  • Advise low-purine diet (reduce red meat, organ meats, shellfish, alcohol)
  • Ensure adequate hydration
  • Monitor every 6 months; if rises above 8 or patient develops gout symptoms, start Allopurinol 100mg OD

5. LIPID PROFILE - Borderline Triglycerides

• Triglycerides 141 mg/dL (borderline, target <150 for diabetics ideally <130)
• Total cholesterol 127, LDL 68, HDL 49 - all acceptable
• Action: Dietary modification (reduce refined carbs, sugar, alcohol)
• Statin therapy consideration: Per current guidelines, all diabetic patients >40 years with any CV risk factor should be on a moderate-intensity statin regardless of LDL level. Consider Atorvastatin 10-20mg OD (also cardioprotective in T2DM)

6. LIFESTYLE MODIFICATIONS (Non-negotiable)

• Diet: Low glycaemic index, Mediterranean-style diet; reduce refined carbohydrates, white rice, sugar; increase fiber
• Physical activity: 150 min/week of moderate aerobic exercise (brisk walking 30 min, 5 days/week)
• Weight management: Assess BMI - if overweight, target 5-10% weight reduction
• Self-monitoring: Home glucometer fasting + 2hr post-meal glucose monitoring
• CGM: ADA 2025 now recommends CGM consideration even for T2DM not on insulin

7. INVESTIGATIONS TO ORDER NOW

Summary Prescription Plan

⚕️ Clinical Note: The most pressing issue beyond glycemic control is the persistent thrombocytopenia (now 125, trending down from 152), lymphocytosis, and macrocytosis. This triad must be investigated urgently with a peripheral smear and B12/folate levels before attributing it solely to metformin. A hematology referral should be considered if the smear shows any atypical cells or if platelet count drops further.